Source:http://linkedlifedata.com/resource/pubmed/id/20048709
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2010-1-5
|
pubmed:abstractText |
To summarize recent progress in the development of adjuvants with a special focus on adjuvants that enhance B-cell responses to protein-based vaccines. Both established and new experimental approaches are described and also briefly we discuss how adjuvants and virus-based vaccines interact with the immune system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1746-6318
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
441-6
|
pubmed:meshHeading |
pubmed-meshheading:20048709-AIDS Vaccines,
pubmed-meshheading:20048709-Adjuvants, Immunologic,
pubmed-meshheading:20048709-Antibodies, Neutralizing,
pubmed-meshheading:20048709-B-Lymphocytes,
pubmed-meshheading:20048709-HIV Antibodies,
pubmed-meshheading:20048709-HIV-1,
pubmed-meshheading:20048709-Humans
|
pubmed:year |
2009
|
pubmed:articleTitle |
Novel adjuvants for B cell immune responses.
|
pubmed:affiliation |
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|